AIM ImmunoTech Inc.
AIM
$0.12
-$0.0034-2.76%
Weiss Ratings | AIM - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D- | |||
Reward Grade | E | |||
Rating Factors | AIM - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Fair | |||
Total Return Index | Very Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | AIM - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.45 | |||
Price History | AIM - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -2.76% | |||
30-Day Total Return | -39.76% | |||
60-Day Total Return | -43.66% | |||
90-Day Total Return | -52.57% | |||
Year to Date Total Return | -44.70% | |||
1-Year Total Return | -66.67% | |||
2-Year Total Return | -74.19% | |||
3-Year Total Return | -84.42% | |||
5-Year Total Return | -95.79% | |||
52-Week High % Change | -80.10% | |||
52-Week Low % Change | 11.67% | |||
Price | AIM - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $0.62 | |||
52-Week Low Price | $0.11 | |||
52-Week Low Price (Date) | Feb 25, 2025 | |||
52-Week High Price (Date) | Apr 11, 2024 | |||
Valuation | AIM - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 7.87M | |||
Enterprise Value | 4.07M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.48 | |||
Earnings Per Share Growth | 9.85% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 38.56 | |||
Price/Book (Q) | 2.49 | |||
Enterprise Value/Revenue (TTM) | 21.42 | |||
Price | $0.12 | |||
Enterprise Value/EBITDA (TTM) | -0.15 | |||
Enterprise Value/EBIT | -0.15 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | AIM - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 57.68M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | AIM - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 352 448 7797 | |||
Address | 2117 SW Highway 484 Ocala, FL 34473 | |||
Website | aimimmuno.com | |||
Country | United States | |||
Year Founded | 1966 | |||
Profitability | AIM - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -14,695.26% | |||
Profit Margin | -12,594.21% | |||
Management Effectiveness | AIM - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -84.20% | |||
Return on Equity | -- | |||
Income Statement | AIM - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 190.00K | |||
Total Revenue (TTM) | 190.00K | |||
Revenue Per Share | $0.00 | |||
Gross Profit (TTM) | 154.00K | |||
EBITDA (TTM) | -27.68M | |||
EBIT (TTM) | -27.92M | |||
Net Income (TTM) | -23.93M | |||
Net Income Avl. to Common (TTM) | -23.93M | |||
Total Revenue Growth (Q YOY) | -23.91% | |||
Earnings Growth (Q YOY) | 52.66% | |||
EPS Diluted (TTM) | -0.48 | |||
EPS Diluted Growth (Q YOY) | 60.05% | |||
Balance Sheet | AIM - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 7.20M | |||
Cash Per Share (Q) | $0.12 | |||
Total Current Assets (Q) | 7.57M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 2.91M | |||
Current Ratio (Q) | 0.750 | |||
Book Value Per Share (Q) | $0.05 | |||
Total Assets (Q) | 13.59M | |||
Total Current Liabilities (Q) | 10.10M | |||
Total Debt (Q) | 3.40M | |||
Total Liabilities (Q) | 10.68M | |||
Total Common Equity (Q) | 2.91M | |||
Cash Flow | AIM - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | 788.00K | |||
Cash from Financing (TTM) | 5.55M | |||
Net Change in Cash (TTM) | -14.35M | |||
Levered Free Cash Flow (TTM) | -14.97M | |||
Cash from Operations (TTM) | -20.69M | |||